Found: 37
Select item for more details and to access through your institution.
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. c4, doi. 10.1111/dom.14961
- By:
- Publication type:
- Article
Response to letter from Du et al. regarding article 'Sodium‐glucose cotransporter‐2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?'.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 630, doi. 10.1111/dom.14913
- By:
- Publication type:
- Article
Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 618, doi. 10.1111/dom.14900
- By:
- Publication type:
- Article
Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 581, doi. 10.1111/dom.14904
- By:
- Publication type:
- Article
Associations of liver fat content with cardiometabolic phenotypes and outcomes in a multi‐ethnic population: Results from the Dallas Heart Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 586, doi. 10.1111/dom.14905
- By:
- Publication type:
- Article
Comparative effects of weight loss and incretin‐based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 570, doi. 10.1111/dom.14903
- By:
- Publication type:
- Article
Eight‐year trends in obesity‐related complications and health care cost progression in a US population with obesity: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 536, doi. 10.1111/dom.14897
- By:
- Publication type:
- Article
Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 596, doi. 10.1111/dom.14906
- By:
- Publication type:
- Article
Is intestinal permeability increased in obesity? A review including the effects of dietary, pharmacological and surgical interventions on permeability and the microbiome.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 325, doi. 10.1111/dom.14899
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real‐world clinical practice? A systematic review and meta‐analysis of observational studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 501, doi. 10.1111/dom.14893
- By:
- Publication type:
- Article
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 556, doi. 10.1111/dom.14902
- By:
- Publication type:
- Article
Weight regain after behavioural weight management programmes and its impact on quality of life and cost effectiveness: Evidence synthesis and health economic analyses.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 526, doi. 10.1111/dom.14895
- By:
- Publication type:
- Article
A simplified straightforward protocol for the use of U‐500 regular insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 634, doi. 10.1111/dom.14896
- By:
- Publication type:
- Article
Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005‐2018.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 516, doi. 10.1111/dom.14894
- By:
- Publication type:
- Article
Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 545, doi. 10.1111/dom.14898
- By:
- Publication type:
- Article
Once‐weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis based on SUSTAIN 11.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 491, doi. 10.1111/dom.14892
- By:
- Publication type:
- Article
Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: A randomized double‐blind, placebo‐controlled Phase 2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 479, doi. 10.1111/dom.14891
- By:
- Publication type:
- Article
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 468, doi. 10.1111/dom.14890
- By:
- Publication type:
- Article
Factors associated with successful weight loss after liraglutide treatment for obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 377, doi. 10.1111/dom.14880
- By:
- Publication type:
- Article
Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 444, doi. 10.1111/dom.14888
- By:
- Publication type:
- Article
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 435, doi. 10.1111/dom.14887
- By:
- Publication type:
- Article
Impact of iron supplementation on gestational diabetes mellitus: A literature review.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 342, doi. 10.1111/dom.14886
- By:
- Publication type:
- Article
Age‐specific associations between the number of co‐morbidities, all‐cause mortality and public direct medical costs in patients with type 2 diabetes: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 454, doi. 10.1111/dom.14889
- By:
- Publication type:
- Article
The impact of family history of type 2 diabetes on clinical heterogeneity in idiopathic type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 417, doi. 10.1111/dom.14884
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
Change in pharmacodynamic variables following once‐weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J‐mono substudy).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 398, doi. 10.1111/dom.14882
- By:
- Publication type:
- Article
Cost‐utility analysis of semaglutide for type 2 diabetes after its addition to the National Medical Insurance System in China.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 387, doi. 10.1111/dom.14881
- By:
- Publication type:
- Article
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 426, doi. 10.1111/dom.14885
- By:
- Publication type:
- Article
Testing for association between exonic glucagon‐like peptide 1 receptor mutation with physical and brain health traits in UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 623, doi. 10.1111/dom.14879
- By:
- Publication type:
- Article
Sodium‐glucose cotransporter‐2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 628, doi. 10.1111/dom.14878
- By:
- Publication type:
- Article
Non‐alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 365, doi. 10.1111/dom.14877
- By:
- Publication type:
- Article
Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 354, doi. 10.1111/dom.14876
- By:
- Publication type:
- Article
Ethnicity and risks of severe COVID‐19 outcomes associated with glucose‐lowering medications: A cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 611, doi. 10.1111/dom.14872
- By:
- Publication type:
- Article
Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 331, doi. 10.1111/dom.14871
- By:
- Publication type:
- Article
Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 602, doi. 10.1111/dom.14854
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 323, doi. 10.1111/dom.14749
- Publication type:
- Article